Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lanraplenib |
Trade Name | |
Synonyms | GS-9876 |
Drug Descriptions |
Lanraplenib inhibits Syk, resulting in decreased B-cell receptor (BCR) signaling and potentially leading to decreased tumor cell activation and proliferation (NCI Drug Dictionary). |
DrugClasses | SYK Inhibitor 15 |
CAS Registry Number | 1800046-95-0 |
NCIT ID | C174607 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gilteritinib + Lanraplenib | Gilteritinib Lanraplenib | 0 | 1 |
Lanraplenib | Lanraplenib | 0 | 0 |